Colgate-Palmolive Company
CLConsumer DefensiveNASDAQHousehold & Personal Products
Scan Results
Daily timeframeHeadquartered within the consumer defensive sector, Colgate-Palmolive Company focuses on Household & Personal Products services and products. Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. At a $70.48B market cap, Colgate-Palmolive Company ranks as a large-cap company within consumer defensive. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition.
Market Cap
$70.48B
Beta
0.32
P/E (TTM)
34.81
P/E (Fwd)
21.52
EPS (TTM)
$2.54
EPS (Fwd)
$4.11
ROE
267.4%
ROA
15.8%
Cash
$1.45B
Total Debt
$7.86B
Free CF
$3.46B
52W Change
6.7%
Annual Financials
Cash vs Debt
Where CL stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, CL finished 0.72% above its 150-day moving average ($89.46) and 3.78% above its 200-day moving average ($86.82). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CL overbought or oversold?
At the September 3, 2026 close, CL's RSI(14) was 39.5, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Colgate-Palmolive Company carries $7.86B in total debt against $1.45B in cash reserves — debt is roughly 5.4x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $3.46B in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at 267.4%, which is exceptionally high for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Return on assets of 15.8% further supports the picture of efficient asset utilization. Revenue has been uneven over recent years, ranging from $17.97B to $20.38B.
CL's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing CL.